Skip to main content

Compare Stocks

Date Range: 

 GenetronCastle BiosciencesFulgent GeneticsRadNetDermTech
SymbolNASDAQ:GTHNASDAQ:CSTLNASDAQ:FLGTNASDAQ:RDNTNASDAQ:DMTK
Price Information
Current Price$18.77$52.11$66.80$23.05$30.91
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score0.41.91.61.31.6
Analysis Score1.53.52.11.53.5
Community Score0.62.92.42.63.1
Dividend Score0.00.00.00.00.0
Ownership Score0.02.50.81.70.8
Earnings & Valuation Score0.00.62.50.60.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$19.50$85.00$74.40$24.50$56.00
% Upside from Price Target3.89% upside63.12% upside11.38% upside6.29% upside81.17% upside
Trade Information
Market Cap$1.67 billion$1.31 billion$1.94 billion$1.21 billion$893.48 million
BetaN/A0.461.921.520.99
Average Volume398,784295,9651,828,428196,8361,502,531
Sales & Book Value
Annual Revenue$45.68 million$51.87 million$32.53 million$1.15 billion$3.36 million
Price / Sales36.5225.1759.561.05265.92
CashflowN/A$0.10 per share$0.13 per share$3.61 per shareN/A
Price / CashN/A539.36498.376.38N/A
Book ValueN/A$4.98 per share$4.42 per share$4.63 per share$1.01 per share
Price / Book10.4615.114.9830.60
Profitability
Net Income$-95,470,000.00$5.28 million$-410,000.00$14.76 million$-19,690,000.00
EPSN/A($0.81)$0.02$0.29($2.81)
Trailing P/E Ratio0.00N/A33.07N/AN/A
Forward P/E RatioN/A12.3750.11N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-5.30%35.31%-0.98%-577.75%
Return on Equity (ROE)N/A-2.69%43.81%-2.72%-65.00%
Return on Assets (ROA)N/A-2.05%36.82%-0.37%-58.37%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.07%N/A2.55%N/A
Current Ratio5.74%6.65%3.39%0.69%13.31%
Quick Ratio5.68%6.59%3.39%0.69%13.28%
Ownership Information
Institutional Ownership Percentage19.56%66.42%33.39%67.46%51.35%
Insider Ownership PercentageN/A39.70%45.00%5.77%16.48%
Miscellaneous
Employees7991994806,157114
Shares Outstanding88.87 million25.06 million29.01 million52.34 million28.91 million
Next Earnings Date5/24/2021 (Confirmed)8/9/2021 (Estimated)8/3/2021 (Estimated)8/9/2021 (Estimated)5/13/2021 (Confirmed)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
$2.00 Million in Sales Expected for DermTech, Inc. (NASDAQ:DMTK) This Quarter$2.00 Million in Sales Expected for DermTech, Inc. (NASDAQ:DMTK) This Quarter
americanbankingnews.com - May 13 at 1:58 AM
DermTech (NASDAQ:DMTK) Shares Gap Down to $33.27DermTech (NASDAQ:DMTK) Shares Gap Down to $33.27
americanbankingnews.com - May 12 at 12:40 PM
DermTech, Inc. (NASDAQ:DMTK) Expected to Post Earnings of -$0.47 Per ShareDermTech, Inc. (NASDAQ:DMTK) Expected to Post Earnings of -$0.47 Per Share
americanbankingnews.com - May 11 at 9:24 PM
DermTech Management to Present at the UBS Global Healthcare Virtual Conference - Business WireDermTech Management to Present at the UBS Global Healthcare Virtual Conference - Business Wire
businesswire.com - May 11 at 6:27 PM
DermTech Management to Present at the UBS Global Healthcare Virtual ConferenceDermTech Management to Present at the UBS Global Healthcare Virtual Conference
finance.yahoo.com - May 11 at 6:27 PM
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit - Yahoo FinanceDermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit - Yahoo Finance
finance.yahoo.com - May 11 at 2:02 AM
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit - Business WireDermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit - Business Wire
businesswire.com - May 10 at 9:02 PM
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual SummitDermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit
finance.yahoo.com - May 10 at 9:02 PM
DermTech (NASDAQ:DMTK) Earns Buy Rating from Analysts at BTIG ResearchDermTech (NASDAQ:DMTK) Earns Buy Rating from Analysts at BTIG Research
americanbankingnews.com - May 10 at 10:30 AM
DermTech Inc. (NASDAQ:DMTK) Has Recovered 71.66% So Far, But Another 148.35% Gain Cannot Be Ruled OutDermTech Inc. (NASDAQ:DMTK) Has Recovered 71.66% So Far, But Another 148.35% Gain Cannot Be Ruled Out
marketingsentinel.com - May 9 at 1:14 AM
After A 11.62% Rise This Year Is DermTech Inc. (NASDAQ:DMTK) A Better Buy Than Others?After A 11.62% Rise This Year Is DermTech Inc. (NASDAQ:DMTK) A Better Buy Than Others?
marketingsentinel.com - May 7 at 11:04 PM
Why DermTech, Inc. (NASDAQ:DMTK) Stock Might Be A Good InvestmentWhy DermTech, Inc. (NASDAQ:DMTK) Stock Might Be A Good Investment
stocksregister.com - May 7 at 11:04 PM
DermTech, Inc. (DMTK) May Report Negative Earnings: Know the Trend Ahead of Next Weeks Release - NasdaqDermTech, Inc. (DMTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Nasdaq
nasdaq.com - May 6 at 5:01 PM
DermTech, Inc. (DMTK) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseDermTech, Inc. (DMTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - May 6 at 5:01 PM
DermTech (DMTK) Set to Announce Earnings on ThursdayDermTech (DMTK) Set to Announce Earnings on Thursday
americanbankingnews.com - May 6 at 2:50 AM
DermTech, Inc. (NASDAQ:DMTK) CEO Sells $1,024,000.00 in StockDermTech, Inc. (NASDAQ:DMTK) CEO Sells $1,024,000.00 in Stock
americanbankingnews.com - May 5 at 5:05 PM
DermTech (NASDAQ:DMTK) Stock Price Down 6.1%DermTech (NASDAQ:DMTK) Stock Price Down 6.1%
americanbankingnews.com - May 5 at 3:46 PM
3 Stocks I Fully Expect to Double or More Within the Next 5 Years - Motley Fool3 Stocks I Fully Expect to Double or More Within the Next 5 Years - Motley Fool
fool.com - May 4 at 8:03 AM
3 Stocks I Fully Expect to Double or More Within the Next 5 Years3 Stocks I Fully Expect to Double or More Within the Next 5 Years
finance.yahoo.com - May 4 at 8:03 AM
BTIG Initiates Coverage of DermTech With Buy Rating - 360DxBTIG Initiates Coverage of DermTech With Buy Rating - 360Dx
360dx.com - May 4 at 1:01 AM
DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams - Business WireDermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams - Business Wire
businesswire.com - May 3 at 8:00 PM
DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin ExamsDermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams
finance.yahoo.com - May 3 at 8:00 PM
BTIG Initiates Coverage of DermTech With Buy Rating - GenomeWebBTIG Initiates Coverage of DermTech With Buy Rating - GenomeWeb
genomeweb.com - May 3 at 3:00 PM
BTIG Research Initiates Coverage on DermTech (NASDAQ:DMTK)BTIG Research Initiates Coverage on DermTech (NASDAQ:DMTK)
americanbankingnews.com - May 3 at 8:40 AM
DermTech to Announce First Quarter Financial Results on May 13, 2021 - Yahoo FinanceDermTech to Announce First Quarter Financial Results on May 13, 2021 - Yahoo Finance
finance.yahoo.com - April 30 at 1:17 AM
3 Growth Stocks with Market-Beating Potential3 Growth Stocks with Market-Beating Potential
marketbeat.com - March 2 at 6:16 PM
DateCompanyBrokerageAction
9/30/2020GenetronCanaccord GenuityReiterated Rating
7/14/2020GenetronBTIG ResearchInitiated Coverage
5/6/2021Castle BiosciencesLake Street CapitalInitiated Coverage
3/9/2021Castle BiosciencesRobert W. BairdLower Price Target
2/3/2021Castle BiosciencesKeyCorpBoost Price Target
1/15/2021Castle BiosciencesSVB LeerinkBoost Price Target
3/11/2021Fulgent GeneticsPiper SandlerBoost Price Target
2/1/2021Fulgent GeneticsOppenheimerBoost Price Target
1/8/2021Fulgent GeneticsCredit Suisse GroupDowngrade
9/25/2020Fulgent GeneticsCSFBBoost Price Target
11/5/2019Fulgent GeneticsPiper Jaffray CompaniesUpgrade
3/15/2021RadNetRaymond JamesBoost Price Target
5/26/2020RadNetSidotiBoost Price Target
3/5/2021DermTechCraig HallumBoost Price Target
10/29/2020DermTechWilliam BlairInitiated Coverage
9/11/2020DermTechBrookline Capital ManagementInitiated Coverage
9/10/2020DermTechCowenInitiated Coverage
(Data available from 5/13/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.